Requires drug labeling to include original manufacturer and supply chain information.

The CLEAR LABELS Act amends the Federal Food, Drug, and Cosmetic Act to mandate that drug labeling include the name, place of business, and unique facility identifier of the original manufacturer for active pharmaceutical ingredients and finished drug products. This applies to both active pharmaceutical ingredients and finished drug products, with exceptions for electronic means of access. The bill also exempts certain finished drug products from customs country of origin marking requirements if they comply with the new labeling rules.

Requires drug labeling to include original manufacturer and supply chain information.

The CLEAR LABELS Act amends the Federal Food, Drug, and Cosmetic Act to mandate that drug labeling include the name, place of business, and unique facility identifier of the original manufacturer for active pharmaceutical ingredients and finished drug products. This applies to both active pharmaceutical ingredients and finished drug products, with exceptions for electronic means of access. The bill also exempts certain finished drug products from customs country of origin marking requirements if they comply with the new labeling rules.